These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32550204)

  • 1. Methylglyoxal and soluble RAGE in type 2 diabetes mellitus: Association with oxidative stress.
    Reyaz A; Alam S; Chandra K; Kohli S; Agarwal S
    J Diabetes Metab Disord; 2020 Jun; 19(1):515-521. PubMed ID: 32550204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma levels of the methylglyoxal in patients with newly diagnosed type 2 diabetes 2.
    Kong X; Ma MZ; Huang K; Qin L; Zhang HM; Yang Z; Li XY; Su Q
    J Diabetes; 2014 Nov; 6(6):535-40. PubMed ID: 24720446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
    Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J
    Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the plasma levels of soluble RAGE and endogenous secretory RAGE with oxidative stress in pre-diabetic patients.
    Huang M; Que Y; Shen X
    J Diabetes Complications; 2015 Apr; 29(3):422-6. PubMed ID: 25659638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum IGF-1, AGEs and their receptors with the risk of colorectal cancer in patients with type 2 diabetes mellitus.
    Chen Z; Hong Q
    Front Oncol; 2023; 13():1125745. PubMed ID: 36890832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes.
    Humpert PM; Djuric Z; Kopf S; Rudofsky G; Morcos M; Nawroth PP; Bierhaus A
    Cardiovasc Diabetol; 2007 Mar; 6():9. PubMed ID: 17343760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children.
    Saito R; Araki S; Yamamoto Y; Kusuhara K
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):63-69. PubMed ID: 27941172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.
    Miranda ER; Fuller KNZ; Perkins RK; Beisswenger PJ; Farabi SS; Quinn L; Haus JM
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
    Kim JK; Park S; Lee MJ; Song YR; Han SH; Kim SG; Kang SW; Choi KH; Kim HJ; Yoo TH
    Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma level of soluble RAGE is independently associated with a low recurrence of atrial fibrillation after catheter ablation in diabetic patient.
    Yang PS; Kim TH; Uhm JS; Park S; Joung B; Lee MH; Pak HN
    Europace; 2016 Nov; 18(11):1711-1718. PubMed ID: 26838688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylglyoxal: A Relevant Marker of Disease Activity in Patients with Rheumatoid Arthritis.
    Knani I; Bouzidi H; Zrour S; Bergaoui N; Hammami M; Kerkeni M
    Dis Markers; 2018; 2018():8735926. PubMed ID: 29606988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients.
    Motawi TM; Abou-Seif MA; Bader AM; Mahmoud MO
    BMC Endocr Disord; 2013 Aug; 13():32. PubMed ID: 23964833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus.
    Skrha J; Kalousová M; Svarcová J; Muravská A; Kvasnička J; Landová L; Zima T; Skrha J
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):277-81. PubMed ID: 22549347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Burden of Impaired Serum Albumin Antioxidant Properties and Glyco-Oxidation in Coronary Heart Disease Patients with and without Type 2 Diabetes Mellitus.
    Piarulli F; Banfi C; Brioschi M; Altomare A; Ragazzi E; Cosma C; Sartore G; Lapolla A
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 36009220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.
    Wang P; Huang R; Lu S; Xia W; Cai R; Sun H; Wang S
    PLoS One; 2016; 11(1):e0145521. PubMed ID: 26745632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
    Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
    Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE.
    Wong FN; Chua KH; Tan JAMA; Wong CM; Kuppusamy UR
    PeerJ; 2018; 6():e4421. PubMed ID: 29610703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients.
    Villegas-Rodríguez ME; Uribarri J; Solorio-Meza SE; Fajardo-Araujo ME; Cai W; Torres-Graciano S; Rangel-Salazar R; Wrobel K; Garay-Sevilla ME
    PLoS One; 2016; 11(7):e0159175. PubMed ID: 27434539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.